Literature DB >> 19360048

Cutting off cancer's supply lines.

Erika Check Hayden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19360048     DOI： 10.1038/458686b

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

Review 1.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

2.  Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

Authors:  Selma Pennacchietti; Paolo Michieli; Maria Galluzzo; Massimiliano Mazzone; Silvia Giordano; Paolo M Comoglio
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

3.  Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.

Authors:  John M L Ebos; Christina R Lee; William Cruz-Munoz; Georg A Bjarnason; James G Christensen; Robert S Kerbel
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

4.  Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.

Authors:  Marta Pàez-Ribes; Elizabeth Allen; James Hudock; Takaaki Takeda; Hiroaki Okuyama; Francesc Viñals; Masahiro Inoue; Gabriele Bergers; Douglas Hanahan; Oriol Casanovas
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743
  4 in total
  12 in total

1.  Fighting against cancer by integrative medicine.

Authors:  Zhao-you Tang
Journal:  Chin J Integr Med       Date:  2012-05-02       Impact factor: 1.978

2.  VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer.

Authors:  Weon-Kyoo You; Barbara Sennino; Casey W Williamson; Beverly Falcón; Hiroya Hashizume; Li-Chin Yao; Dana T Aftab; Donald M McDonald
Journal:  Cancer Res       Date:  2011-05-25       Impact factor: 12.701

3.  A retroperitoneal NF1-independent malignant peripheral nerve sheath tumor with elevated serum CA125: case report and discussion.

Authors:  Bing Yan; Xianze Meng; Bian Shi; Jun Shi; Zhifeng Qin; Pinkang Wei
Journal:  J Neurooncol       Date:  2012-04-19       Impact factor: 4.130

Review 4.  Are cancer stem cells radioresistant?

Authors:  Walter N Hittelman; Yong Liao; Li Wang; Luka Milas
Journal:  Future Oncol       Date:  2010-10       Impact factor: 3.404

5.  Noninvasive assessment of tumor VEGF receptors in response to treatment with pazopanib: a molecular imaging study.

Authors:  Francis G Blankenberg; Zoia Levashova; Susanta K Sarkar; John Pizzonia; Marina V Backer; Joseph M Backer
Journal:  Transl Oncol       Date:  2010-02       Impact factor: 4.243

6.  Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis.

Authors:  Wen-guo Jiang; Xin-an Lu; Bo-yang Shang; Yan Fu; Sheng-hua Zhang; Daifu Zhou; Liang Li; Yi Li; Yongzhang Luo; Yong-su Zhen
Journal:  BMC Cancer       Date:  2013-10-15       Impact factor: 4.430

Review 7.  Zebrafish-Based Screening Models for the Identification of Anti-Metastatic Drugs.

Authors:  Joji Nakayama; Hideki Makinoshima
Journal:  Molecules       Date:  2020-05-21       Impact factor: 4.411

8.  Condurango (Gonolobus condurango) Extract Activates Fas Receptor and Depolarizes Mitochondrial Membrane Potential to Induce ROS-dependent Apoptosis in Cancer Cells in vitro: CE-treatment on HeLa: a ROS-dependent mechanism.

Authors:  Kausik Bishayee; Jesmin Mondal; Sourav Sikdar; Anisur Rahman Khuda-Bukhsh
Journal:  J Pharmacopuncture       Date:  2015-09

9.  Endothelial Dll4 overexpression reduces vascular response and inhibits tumor growth and metastasization in vivo.

Authors:  Alexandre Trindade; Dusan Djokovic; Joana Gigante; Liliana Mendonça; António Duarte
Journal:  BMC Cancer       Date:  2017-03-14       Impact factor: 4.430

Review 10.  The MUDENG Augmentation: A Genesis in Anti-Cancer Therapy?

Authors:  Manikandan Muthu; Sechul Chun; Judy Gopal; Gyun-Seok Park; Arti Nile; Jisoo Shin; Juhyun Shin; Tae-Hyoung Kim; Jae-Wook Oh
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.